APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM NEW
Total 13F shares
811,717
Share change
+51,143
Total reported value
$4,763,000
Price per share
$5.87
Number of holders
18
Value change
+$288,471
Number of buys
7
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q1 2022

As of 31 Mar 2022, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 811,717 shares. The largest 10 holders included VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, BARCLAYS PLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 18 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.